Vaccination protects β2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection
- 30 September 1996
- Vol. 14 (13) , 1223-1229
- https://doi.org/10.1016/s0264-410x(96)00028-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Role of CD4+ T Cells in Cell‐Mediated Immunity to LCM V: Studies in MHC Class I and Class II Deficient MiceScandinavian Journal of Immunology, 1994
- Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus VaccineThe Journal of Infectious Diseases, 1994
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994
- Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cellsEuropean Journal of Immunology, 1993
- LCMV-Specific, Class II-Restricted Cytotoxic T Cells in β2-Microglobulin-Deficient MiceScience, 1992
- Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T CellsScience, 1990
- β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cellsNature, 1990
- Major histocompatibility complex – dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral diseaseEuropean Journal of Immunology, 1989
- Anti‐viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia‐recombinant virus expressing LCMV‐WE nucleoprotein or glycoproteinEuropean Journal of Immunology, 1989
- Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.The Journal of Experimental Medicine, 1984